ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2357

Vascular Adhesion Molecule-1 Overexpression in Collagen-Induced Arthritis: Modeling Vascular Dysfunction in Rheumatoid Arthritis

Luca Semerano1,2, Gaelle Clavel3, Delphine Lemeiter4, Marie-Christophe Boissier4,5 and Anne Denys1, 1INSERM UMR U1125, University Paris 13, Sorbonne Paris Cité, Bobigny, France, 2Rheumatology, Avicenne Teaching Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP),, Bobigny, France, 3Fondation Ophtalmologique A. De Rothschild, Paris cedex 19, France, 4INSERM UMR 1125, Li2P, University Paris 13, Sorbonne Paris Cité, Bobigny, France, 5Rheumatology, AvicenneTeaching Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Adhesion molecules, Animal models, cardiovascular disease and rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Animal Models

Session Type: Abstract Submissions (ACR)

 

Vascular adhesion molecule-1 Overexpression in collagen-induced arthritis: modeling vascular dysfunctionS in rheumatoid arthritis

 

   Background/Purpose: Rheumatoid Arthritis (RA) patients are at risk of developing primary coronary heart disease earlier than general population. Increased cardiovascular risk in RA is attributed to both traditional Framingham risk factors and systemic inflammation over a long period.

Limited experimental data exist on vascular involvement in arthritis models.

The aim of our study was to model vascular dysfunctions and inflammation in RA using CIA. We focused on VCAM-1, IL-17 and iNOS expression in aorta removed 15 weeks after arthritis induction.

   Methods:

Arthritis was induced in C57BL mice (11 week old) by 2 injections within 21 days of chicken CII (cCII) emulsioned in Adjuvant (CFA). Half of these mice (n=12) were fed with a hyperlipidic diet (HD and the other half (n=12) with a standard diet. The control mice were not immunized (NI) but were fed either the standard diet (n=12) or HD (n=12). Aorta and synovial membranes were removed 15 weeks after the first immunization. We analysed VCAM-1, iNOS and IL-17 mRNA level in aorta by real time quantitative PCR (qRT-PCR). VCAM-1 localisation in the aortic sinus layers (intima, media and adventitia) was determined by immunohistochemistry (IHC).

   Results:

VCAM-1 expression was increased in aorta from CIA mice compared to NI mice, regardless of the fed diet (fig.1).  Conversely, iNOS expression was increased in aorta from HD fed mice, whether immunized or not (fig.2). The expression of IL-17 in the aorta was not affected by collagen immunization or diet

   Conclusion:

CIA in C57BL6 mice is accompanied by large vessel inflammation. Collagen immunization induced vascular dysfunctions marked by VCAM-1 overexpression independently of the diet. Conversely, HD diet induced a distinct profile of vessel inflammation characterized by high iNOS expression. CIA may be a pertinent model to study cardiovascular disease in RA.

 

£: p<0.05 vs.HD and NI                                                    *: p<0.05 vs. CIA and NI


Disclosure:

L. Semerano,
None;

G. Clavel,
None;

D. Lemeiter,
None;

M. C. Boissier,
None;

A. Denys,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/vascular-adhesion-molecule-1-overexpression-in-collagen-induced-arthritis-modeling-vascular-dysfunction-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology